Literature DB >> 6087306

Beta-adrenoceptor and epoprostenol (prostacyclin) responsiveness of lymphocytes in migraine patients.

S A Kilfeather, A Massarella, G Gorgolewska, E Ansell, P Turner.   

Abstract

Beta-adrenoceptor blocking drugs are of prophylactic value in some patients with migraine. Beta-adrenoceptor responsiveness as measured by lymphocyte cAMP responsiveness to isoprenaline has, therefore, been compared in ten untreated classical migraine patients and ten matched non-migraine control subjects. Lymphocyte responsiveness to epoprostenol (prostacyclin, PGI2) was also compared. No difference in response to either agent was found between the two groups. A generalized abnormality of beta-adrenoceptor function does not appear to be present in classical migraine, but a defect localized to specific vascular regions cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087306      PMCID: PMC2417887          DOI: 10.1136/pgmj.60.704.391

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  2 in total

1.  A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate.

Authors:  B L Brown; J D Albano; R P Ekins; A M Sgherzi
Journal:  Biochem J       Date:  1971-02       Impact factor: 3.857

2.  Beta-blocking drugs increase responsiveness to prostacyclin in hypertensive patients.

Authors:  D R Lima; P Turner
Journal:  Lancet       Date:  1982-08-21       Impact factor: 79.321

  2 in total
  2 in total

Review 1.  A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2020-09-24       Impact factor: 5.782

2.  Expression of prostaglandin I2 (prostacyclin) receptor in blood of migraine patients: A potential biomarker.

Authors:  Majid Kheirollahi; Mohammad Kazemi; Gilda Amini; Fariborz Khorvash; Fatemeh Ahangari; Mahsa Kolahdouz; Leila Koulivand
Journal:  Adv Biomed Res       Date:  2015-06-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.